DOI: 10.32098/mltj_2026_7472

Impact of chronic use of fluoxetine hydrochloride on the calcaneal tendon

Authors

  • João Pedro Barros Estanislau Department of Anatomy Institute of Biomedical Science Federal University of Alfenas, UNIFAL-MG, Alfenas, Brazil
  • Pedro Magalhães Telles Department of Anatomy Institute of Biomedical Science Federal University of Alfenas, UNIFAL-MG, Alfenas, Brazil
  • Wagner Costa Rossi Junior Department of Anatomy Institute of Biomedical Science Federal University of Alfenas, UNIFAL-MG, Alfenas, Brazil
  • Petrus Pires Marques School of Medicine José do Rosário Vellano University-Unifenas, Alfenas, Brazil
  • Flávia Da Ré Guerra Department of Anatomy Institute of Biomedical Science Federal University of Alfenas, UNIFAL-MG, Alfenas, Brazil

flavia.guerra@unifal-mg.edu.br

Keywords

Collagen, glycosaminoglycans, Achilles tendon, calcaneal tendon, ligament, extracellular matrix, fluoxetine

Abstract

Introduction: Fluoxetine hydrochloride, in addition to its antidepressant effects in the treatment of psychiatric disorders, appears to influence the process of ligament repair. This study investigated its effects on the calcaneal tendon.
Aim: The aim of this study was to evaluate the influence of chronic use of fluoxetine hydrochloride on the morphology of healthy calcaneal tendons, their glycosaminoglycan distribution, and the organization of collagen fibers in rats from different groups using microscopic analysis.
Methods: 25 male rats of the Wistar rats were divided into two groups, the control and fluoxetine-treated groups, and after 60 days, they were euthanized and the tendons were processed for microscopic analysis.
Results: The tendons of rats treated with fluoxetine showed greater thickening and greater disorganization of fibers and cells, as well as less collagen deposition, compared to the control group.
Conclusion: Chronic use of fluoxetine hydrochloride had a significant impact on tendons, weakening their structures and predisposing them to future injuries.

View the entire article

Downloads

References

  1. Kessler RC, Ormel J, Petukhova M, McLaughlin KA, Green JG, Russo LJ, et al. Development of Lifetime Comorbidity in the World Health Organization World Mental Health Surveys. Arch Gen Psychiatry. 2011;68(1):90. doi: 10.1001/archgenpsychiatry.2010.180.
  2. Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2197–223. doi: 10.1016/S0140-6736(12)61689-4.
  3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. 5. ed. Porto Alegre: Artmed, 2014.
  4. Wilde MI, Benfield P. Fluoxetine: A pharmacoeconomic review of its use in depression. Pharmacoeconomics. 1998;13(5):543–61. doi: 10.2165/00019053-199813050-00007.
  5. Montgomery SA. Efficacy and safety of the selective serotonin reuptake inhibitors in treating depression in elderly patients. Int Clin Psychopharmacol. 1998;13:S49–54. doi: 10.1097/00004850-199809005-00010.
  6. Garrison GD, Levin GM. Factors Affecting Prescribing of the Newer Antidepressants. Ann Pharmacother. 2000;34(1):10–4. doi: 10.1345/aph.19079.
  7. Arroll B, Elley CR, Fishman T, Goodyear-Smith FA, Kenealy T, Blashki G, et al. Antidepressants versus placebo for depression in primary care. Cochrane Database of Syst Rev. 2009;2014(4). doi: 10.1002/14651858.CD007954.
  8. Magni LR, Purgato M, Gastaldon C, Papola D, Furukawa TA, Cipriani A, et al. Fluoxetine versus other types of pharmacotherapy for depression. Cochrane Database of Syst Rev. 2013;2013(7). doi: 10.1002/14651858.CD004185.pub3.
  9. Sierralta F, Miranda HF, Pinardi G, Mendez M. Interaction of opioids with antidepressant-induced antinociception. Psychopharmacology. 1995;122(4):374–8. doi: 10.1007/BF02246269.
  10. Ardid D, Guilbaud G. Antinociceptive effects of acute and ‘chronic’ injections of tricyclic antidepressant drugs in a new model of mononeuropathy in rats. Pain. 1992;49(2):279–87. doi: 10.1016/0304-3959(92)90152-2.
  11. Abdel-Salam O. Studies on the anti-inflammatory effect of fluoxetine in the rat. Pharmacol Res. 2004;49(2):119–31. doi: 10.1016/j.phrs.2003.07.016.
  12. Abdel-Salam OME, Nofal SM, El-Shenawy SM. Evaluation of the anti-inflammatory and anti-nociceptive effects of different antidepressants in the rat. Pharmacol Res. 2003;48(2):157–65. doi: 10.1016/s1043-6618(03)00106-3.
  13. Branco-de-Almeida LS, Franco GC, Castro ML, dos Santos JG, Anbinder AL, Cortelli SC, et al. Fluoxetine Inhibits Inflammatory Response and Bone Loss in a Rat Model of Ligature-Induced Periodontitis. J Periodontol. 2012;83(5):664–71. doi: 10.1902/jop.2011.110370.
  14. Sacre S, Medghalchi M, Gregory B, Brennan F, Williams R. Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll-like receptors. Arthritis Rheum. 2010;62(3):683–93. doi: 10.1002/art.27304.
  15. Yaron I, Shirazi I, Judovich R, Levartovsky D, Caspi D, Yaron M. Fluoxetine and amitriptyline inhibit nitric oxide, prostaglandin E2, and hyaluronic acid production in human synovial cells and synovial tissue cultures. Arthritis Rheum. 1999;42(12):2561–8. doi: 10.1002/1529-0131(199912)42:12<2561::AID-ANR8>3.0.CO;2-U.
  16. Branco-de-Almeida LS, Kajiya M, Cardoso CR, Silva MJB, Ohta K, Rosalen PL, et al. Selective serotonin reuptake inhibitors attenuate the antigen presentation from dendritic cells to effector T lymphocytes. FEMS Immunol Med Microbiol. 2011;62(3):283–94. doi: 10.1111/j.1574-695X.2011.00816.x.
  17. Egeland M, Warner-Schmidt J, Greengard P, Svenningsson P. Neurogenic Effects of Fluoxetine Are Attenuated in p11 (S100A10) Knockout Mice. Biol Psychiatry. 2010;67(11):1048–56. doi: 10.1016/j.biopsych.2010.01.024.
  18. Maffulli N, Cuozzo F, Migliorini F, Oliva F. The tendon unit: biochemical, biomechanical, hormonal influences. J Orthop Surg Res. 2023;18(1):311. doi: 10.1186/s13018-023-03796-4.
  19. Ozturk M, Egemen O, Basat S, Bozdag E, Sakiz D, Akan M. Histologic and Biomechanical Evaluation of the Effects of Social Stress and the Antidepressant Fluoxetine on Tendon Healing in Rats. J Hand Microsurg. 2016;07(02):294–9. doi: 10.1007/s12593-015-0204-4.
  20. Li Q, Huang F, Liu J, Zhao YH, Zhang M, Chen YJ. Psychological Stress Alters Extracellular Matrix Metabolism in Mandibular Condylar Cartilage. Chin J Dent Res. 2017;20(3):125–35. doi: 10.3290/j.cjdr.a38767.
  21. Li X qin, Wang H ming, Yang C guang, Zhang X hua, Han D dan, Wang H liang. Fluoxetine inhibited extracellular matrix of pulmonary artery and inflammation of lungs in monocrotaline-treated rats. Acta Pharmacol Sin. 2011;32(2):217–22. doi: 10.1038/aps.2010.187.
  22. Whitmore ja, Lyons JG, Berkay F, Minhas A. Epidemiology of Acute Primary Tendon Ruptures Presenting to Emergency Departments in the United States. Orthopaedic Journal of Sports Medicine. 2025; 13 (8): 23259671251360402. doi: 10.1177/23259671251360402.
  23. Oliva F, Marsilio E, Asparago G, Giai Via A, Biz C, Padulo J, Spoliti M, Foti C, Oliva G, Mannarini S, Rossi AA, Ruggieri P, Maffulli N. Achilles Tendon Rupture and Dysmetabolic Diseases: A Multicentric, Epidemiologic Study. J Clin Med. 2022;11(13):3698. doi: 10.3390/jcm11133698.
  24. Biz C, Cerchiaro M, Belluzzi E, Bragazzi NL, De Guttry G, Ruggieri P. Long Term Clinical-Functional and Ultrasound Outcomes in Recreational Athletes after Achilles Tendon Rupture: Ma and Griffith versus Tenolig. Medicina (Kaunas). 2021;57(10):1073. doi: 10.3390/medicina57101073.
  25. Cuquetto DC, Mill JG, Amaral FT do. Influência do uso de fluoxetina sobre o tempo de corrida em esteira ergométrica em ratos não treinados. Rev. bras. educ. fís. esporte 2012;26(3):375–81. https://doi.org/10.1590/S1807-55092012000300003.
  26. Fernandes AM, Fero K, Arrenberg AB, Bergeron SA, Driever W, Burgess HA. Deep brain photoreceptors control light-seeking behavior in zebrafish larvae. Curr biol : CB. 2012;22(21):2042–7. doi: 10.1016/j.cub.2012.08.016.
  27. De Campos Vidal B, Mello MLS. Collagen type I amide I band infrared spectroscopy. Micron. 2011;42(3):283–9. doi: 10.1016/j.micron.2010.09.010.
  28. Tarantino D, Palermi S, Sirico F, Corrado B. Achilles Tendon Rupture: Mechanisms of Injury, Principles of Rehabilitation and Return to Play. J Funct Morphol Kinesiol. 2020;5(4):95. doi: 10.3390/jfmk5040095.
  29. Wang C, Lin Y, Ye L, Chi Z, Su Z. Ultrasound-assisted minimally invasive repair of acute Achilles tendon rupture with a shuttling needle. J Orthop Surg Res. 2025;20(1):813. doi: 10.1186/s13018-025-06239-4.
  30. Yoon JP, Yoon JW, Kim HM, Oh JH. Selective Serotonin Reuptake Inhibitor Promotes Bone-Tendon Interface Healing in a Rotator Cuff Tear Rat Model. Tissue Eng Regen Med. 2022;19(4):853–60. doi: 10.1007/s13770-022-00444-6.
  31. Özbay H, Atçi T, Adanir O, Alagöz E, Çay T. Effects of social stress and fluoxetine treatment on fracture healing in a rat femur fracture model. Injury. 2022;53(2):362–7. doi: 10.1016/j.injury.2021.11.049.
  32. Gouin JP, Kiecolt-Glaser JK. The Impact of Psychological Stress on Wound Healing. Crit Care Nurs Clin North Am. 2012;24(2):201–13. doi: 10.1016/j.ccell.2012.03.006.
  33. Walburn J, Vedhara K, Hankins M, Rixon L, Weinman J. Psychological stress and wound healing in humans: A systematic review and meta-analysis. J Psychosom Res. 2009;67(3):253–71. doi: 10.1016/j.jpsychores.2009.04.002.
  34. James R, Kesturu G, Balian G, Chhabra AB. Tendon: Biology, Biomechanics, Repair, Growth Factors, and Evolving Treatment Options. J Hand Surg Am. 2008;33(1):102–12. doi: 10.1016/j.jhsa.2007.09.007.

Published

2026-08-25

How to Cite

1.
Barros Estanislau JP, Magalhães Telles P, Costa Rossi Junior W, Pires Marques P, Da Ré Guerra F. Impact of chronic use of fluoxetine hydrochloride on the calcaneal tendon. MLTJ [Internet]. 2026 Aug. 25 [cited 2026 Nov. 20];16(3). Available from: https://mltj.online/index.php/mltj/article/view/7472

Most read articles by the same author(s)